Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820423) titled 'Multimodal AI Predicts High-risk Pathology in Lung Cancer Associated With Cystic Airspaces' on Sept. 3.

Study Type: Observational

Primary Sponsor: Central South University

Condition: Lung Cancer Associated With Cystic Airspaces

Recruitment Status: Recruiting

Date of First Enrollment: May 1, 2025

Target Sample Size: 600

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07820423

Disclaimer: Curated by HT Syndication....